Effect of deflazacort and prednisone on muscle enzymes in the treatment of Duchenne muscular dystrophy

被引：0
|
作者：
Dubow, J. [1 ]
Cunniff, T. [1 ]
Wanaski, S. [1 ]
Meyer, J. [1 ]
机构：
[1] Marathon Pharmaceut, Northbrook, IL USA
来源：
NEUROMUSCULAR DISORDERS | 2016年 / 26卷
关键词：
D O I：
10.1016/j.nmd.2016.06.341
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.312
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [41] Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy
    Shieh, Perry B.
    Elfring, Gary
    Trifillis, Panayiota
    Santos, Claudio
    Peltz, Stuart W.
    Parsons, Julie A.
    Apkon, Susan
    Darras, Basil T.
    Campbell, Craig
    McDonald, Craig M.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (18) : 1337 - 1347
  • [42] Deflazacort or Prednisone Treatment for Duchenne muscular Dystrophy: A Mete-Analysis of Disease Progression Rates in Recent Multicenter Clinical Trials
    Signorovitch, James
    Schilling, Traci
    Sajeev, Gautam
    Yao, Zhiwen
    McDonnell, Erin
    Elfring, Gary
    Souza, Marcio
    Peltz, Stuart
    Darras, Basil
    Shieh, Perry
    McDonald, Craig
    NEUROLOGY, 2019, 92 (15)
  • [43] Deflazacort or Prednisone Treatment for Duchenne Muscular Dystrophy: A Meta-analysis of Disease Progression Rates in Two Multicenter Clinical Trials
    Signorovitch, J.
    Sajeev, G.
    Yao, Z.
    McDonnell, E.
    Elfring, G.
    Trifillis, P.
    Souza, M.
    Speltz, S.
    Darras, B.
    Shieh, P.
    McDonald, C.
    ANNALS OF NEUROLOGY, 2019, 86 : S128 - S129
  • [44] DEFLAZACORT OR PREDNISONE TREATMENT FOR DUCHENNE MUSCULAR DYSTROPHY: A META-ANALYSIS OF DISEASE PROGRESSION RATES IN RECENT MULTICENTER CLINICAL TRIALS
    Signorovitch, J. E.
    Sajeev, G.
    McDonnell, E.
    Yao, Z.
    VALUE IN HEALTH, 2017, 20 (09) : A718 - A718
  • [45] Glucocorticoids deflazacort and prednisone show muscle strength effects versus placebo in boys with Duchenne muscular dystrophy ages 5-7
    Sazani, P.
    Cunniff, T.
    Wanaski, S.
    Dubow, J.
    Meyer, J.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S181 - S182
  • [46] DEFLAZACORT OR PREDNISONE TREATMENT FOR DUCHENNE MUSCULAR DYSTROPHY: A META-ANALYSIS OF DISEASE PROGRESSION RATES IN TWO MULTICENTER CLINICAL TRIALS
    Signorovitch, James
    Sajeev, Gautam
    Yao, Zhiwen
    McDonnell, Erin
    Elfring, Gary
    Trifillis, Panayiota
    Souza, Marcia
    Peltz, Stuart
    Darras, Basil
    Shieh, Perry B.
    McDonald, Craig
    MUSCLE & NERVE, 2019, 60 : S13 - S13
  • [47] Associations between deflazacort vs prednisone/prednisolone and disease progression markers in subgroups of patients with Duchenne muscular dystrophy
    McDonald, C.
    Wing, J.
    Powell, A.
    Mastrandrea, N.
    Signorovitch, J.
    Marden, J.
    Lane, H.
    Zhang, A.
    Nguyen, H.
    ANNALS OF NEUROLOGY, 2022, 92 : S155 - S155
  • [48] Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys
    Tawalbeh, Shefa
    Samsel, Alison
    Gordish-Dressman, Heather
    Hathout, Yetrib
    Dang, Utkarsh J.
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04): : 1 - 17
  • [49] Deflazacort in Duchenne muscular dystrophy: a profile of its use in the USA
    McKeage K.
    Lyseng-Williamson K.A.
    Drugs & Therapy Perspectives, 2018, 34 (1) : 16 - 22
  • [50] Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols
    Biggar, WD
    Politano, L
    Harris, VA
    Passamano, L
    Vajsar, J
    Alman, B
    Palladino, A
    Comi, LI
    Nigro, G
    NEUROMUSCULAR DISORDERS, 2004, 14 (8-9) : 476 - 482
12345